Sekine Yoshitaka

セキネヨシタカ | Sekine Yoshitaka

Affiliation and department：
Job title： Assistant Professor

Research field (1)： Urology

Research theme for competitive and other funds (7)：

2022 - 2025 神経内分泌細胞分化前立腺癌における脂質代謝を介した増殖メカニズムの基礎的検討
2019 - 2022 Combination therapy of PARP inhibitor, statin and platinum-containing drug for prostate cancer
2016 - 2019 Combination therapy with X-ray or heavy ion therapy and statin for prostate cancer
2015 - 2018 Lipid and steroid metabolism and prostate cancer using imaging mass-spectrometry
2013 - 2015 Effect of statins on de novo steroid synthesis pathways in androgen independent prostate cancer cells.

Show all

Papers (371)：

Yoshiyuki Miyazawa, Hidekazu Koike, Daisuke Oka, Hidemasa Kawamura, Nobuteru Kubo, Yuhei Miyasaka, Masahiro Onishi, Takahiro Syuto, Yoshitaka Sekine, Hiroshi Matsui, et al. Comparison of sexual function after robot-assisted radical prostatectomy and carbon-ion radiotherapy for Japanese prostate cancer patients using propensity score matching. BMC cancer. 2024. 24. 1. 300-300
Daisuke Oka, Yoshitaka Sekine, Yusuke Tsuji, Hiroshi Nakayama, Yoshiyuki Miyazawa, Seiji Arai, Hidekazu Koike, Kazuhiro Suzuki. Simvastatin Enhances the Radiosensitivity of Androgen-independent Prostate Cancer Cells via Inhibition of RAD51 Expression. Anticancer research. 2024. 44. 1. 93-98
Yoshiyuki Miyazawa, Yoshitaka Sekine, Daisuke Oka, Shun Nakazawa, Yusuke Tsuji, Hiroshi Nakayama, Kazuhiro Suzuki. Simvastatin Induces Autophagy and Inhibits Proliferation in Prostate Cancer Cells. Anticancer research. 2023. 43. 12. 5377-5386
Akira Ohtsu, Seiji Arai, Yuji Fujizuka, Yoshiyuki Miyazawa, Masashi Nomura, Yoshitaka Sekine, Hidekazu Koike, Hiroshi Matsui, Yasuhiro Shibata, Kazuto Ito, et al. Predictive models of long-term survival outcomes following radical cystectomy. Cancer Medicine. 2023
松井博, 河村英将, 大西真弘, 安達彰子, 岡野奈緒子, 宮澤慶行, 藤塚雄司, 新井誠二, 野村昌史, 関根芳岳, et al. 群馬大学重粒子線医学センターにおける高リスク前立腺癌に対する重粒子線治療. 日本癌治療学会学術集会抄録集. 2023. 61回. P27-2

ｍore...

MISC (97)：

宮澤慶行, 新井誠二, 関根芳岳, 鈴木和浩. ASCO-GU 2021. Espoir : new voyage of prostate cancer / 「Espoir」編集委員会編. 2021. 4. 1. 40-42
鈴木和浩, 周東孝浩, 宮澤慶行, 新井誠二, 関根芳岳. Cardiovascular disease and androgen deprivation therapy for prostate cancer. 月刊泌尿器科. 2021. 13. 4
宮澤慶行, 関根芳岳, 新井誠二, 鈴木和浩. Palliative surgical treatment for Castration Resistant Prostate Cancer patients. Prostate Journal. 2021. 8. 1
宮澤慶行, 河村英将, 北田陽子, 関根芳岳, 新井誠二, 松井博, 鈴木和浩. リスクごとに考える症例からみる前立腺がんの治療と看護症例からみる前立腺がんの治療と看護 06 高リスク・超高リスク:放射線照射(重粒子線). 泌尿器Care & Cure Uro-Lo. 2021. 26. 3
鈴木和浩, 宮澤慶行, 新井誠二, 関根芳岳. Optimal combination/sequence of androgen receptor targeted, chemotherapeutic and molecular targeted agents in patients with castration-resistant prostate cancer. 月刊腫瘍内科. 2021. 28. 4

ｍore...

Lectures and oral presentations (4)：

High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate.
(AUA 106th annual Meeting 2011)
High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate.
(AUA 106th annual Meeting 2011)
High density lipoprotein induces proliferation and migration of human prostate androgen independent cancer cells via ATP-binding cassette transporter A1 by A cholesterol-independent mechanism.
(2010)
High density lipoprotein induces proliferation and migration of human prostate androgen independent cancer cells via ATP-binding cassette transporter A1 by A cholesterol-independent mechanism.
(2010)

Professional career (1)：

Work history (6)：

Show all

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page